DocGo (DCGO) Stock Price, News & Analysis

Company Overview

DocGo, Inc. is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging. The company also partners with public health agencies, employers, universities and event organizers to administer diagnostic testing services for COVID-19 and other infectious diseases. By integrating telehealth, remote patient monitoring and mobile diagnostic capabilities, DocGo aims to streamline access to care, reduce strain on traditional facilities and improve patient outcomes.

DocGo became a publicly traded company in June 2021 following a business combination with SPAC sponsor GigCapital3 Inc., trading on the Nasdaq under the ticker DCGO. Headquartered in Austin, Texas, the company has expanded its reach across multiple U.S. markets, including metropolitan areas in California, Florida, Texas and New York. DocGo’s on-demand approach leverages technology and logistics to enhance convenience, affordability and quality of care for both urban and rural communities.

Key Stats

• Today's Range: $0.66 to $0.70
• 50-Day Range: $0.52 to $0.79
• 52-Week Range: $0.49 to $2.45
• Volume: 329,068 shs
• Average Volume: 953,676 shs
• Market Capitalization: $67.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.38
• Consensus Rating: Hold

DocGo Stock Analysis - MarketRank™

DocGo scored higher than 76% of companies evaluated by MarketBeat, and ranked 155th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Hold

Consensus Rating

DocGo has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 3 buy ratings, 3 hold ratings, and 1 sell rating.

Upside Potential

DocGo has a consensus price target of $2.38, representing about 247.7% upside from its current price of $0.68.

Amount of Analyst Coverage

DocGo has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 466.67%

Earnings Growth

Earnings for DocGo are expected to grow by 466.67% in the coming year, from $0.03 to $0.17 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of DocGo is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DocGo is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DocGo has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.74% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 4.32.

Change versus previous month

Short interest in DocGo has recently increased by 16.52%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DocGo does not currently pay a dividend.

Dividend Growth

DocGo does not have a long track record of dividend growth.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 1.09

News Sentiment

DocGo has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for DocGo this week, compared to 2 articles on an average week.

Search Interest

4 people have searched for DCGO on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DocGo insiders have not sold or bought any company stock.

Percentage Held by Insiders

3.80% of the stock of DocGo is held by insiders.

Percentage Held by Institutions

56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DCGO Stock Analysis - Frequently Asked Questions

How have DCGO shares performed this year?

DocGo's stock was trading at $0.8778 on January 1st, 2026. Since then, DCGO stock has decreased by 22.2% and is now trading at $0.6830.

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) released its quarterly earnings results on Monday, November, 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.02. The company earned $70.81 million during the quarter, compared to analysts' expectations of $69.96 million. DocGo had a negative net margin of 56.61% and a negative trailing twelve-month return on equity of 34.41%.
Read the conference call transcript.

Who are DocGo's major shareholders?

DocGo's top institutional shareholders include Isthmus Partners LLC (1.03%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, James M Travers, Anthony Capone, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko.
View institutional ownership trends.

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of DocGo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 11/10/2025
• Today: 5/05/2026
• Next Earnings (Confirmed): 5/11/2026
• AGM 2026: 6/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:DCGO
• CIK: 1822359
• Web: www.docgo.com
• Phone: 844-443-6246
• Fax: N/A
• Employees: 3,568
• Year Founded: N/A

Price Target and Rating

• Average Price Target for DocGo: $2.38
• High Price Target: $3.00
• Low Price Target: $1.00
• Potential Upside/Downside: +248.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.85)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 22.74
• P/E Growth: N/A
• Net Income: -$182.40 million
• Net Margins: -56.61%
• Pretax Margin: -58.19%
• Return on Equity: -34.41%
• Return on Assets: -23.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.26
• Quick Ratio: 2.26

Sales & Book Value

• Annual Sales: $322.20 million
• Price / Sales: 0.21
• Cash Flow: $0.06 per share
• Price / Cash Flow: 12.19
• Book Value: $1.28 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 98,750,000
• Free Float: 94,998,000
• Market Cap: $67.37 million
• Optionable: Optionable
• Beta: 1.02